Biotech

All Articles

8 months after a $213M fundraise, gene publisher Volume creates cuts

.After rearing $213 million in 2023-- among the year's largest private biotech shots-- Volume Biosci...

BioMarin constructs director staff with biotech veterinarians-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of considerable management hirings, shootings an...

Biopharma Q2 VC attacked highest degree given that '22, while M&ampA slowed down

.Financial backing backing in to biopharma cheered $9.2 billion around 215 handle the 2nd quarter of...

Bicara, Zenas seek IPOs to drive late-phase assets toward market

.Bicara Therapeutics as well as Zenas Biopharma have given new inspiration to the IPO market with fi...

Genentech to shut cancer cells immunology research study division

.Genentech will shut its own cancer immunology investigation division, and device mind and also well...

Kezar drops solid lump but to verify its own worth in phase 1 test

.Kezar Lifestyle Sciences is losing its unpromising phase 1 strong tumor medicine as the biotech goe...

Acelyrin loses izokibep, lays off 3rd of staff

.Despite izokibep keeping its own newfound winning streak in the center, Acelyrin is actually no lon...

Rivus' period 2 obesity-related heart failure test attacks endpoint

.Rivus Pharmaceuticals has plumped up the customers of its own fat-busting, muscle-sparing medicine ...

Ovid halts preclinical job, IV system after soticlestat stop working

.Ovid Therapy presently showed last month that it was trimming back its own head count as the provid...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston ma Seaport

.Eli Lilly has opened up a $700 million R&ampD facility in the Boston Port, increasing its own RNA a...